Close Menu

NEW YORK – Co-Diagnostics said last week that it has been notified by Nasdaq that it failed to meet a listing requirement and may face delisting action.

In a document filed with the US Securities and Exchange Commission, the Salt Lake City-based diagnostics firm said that it received a letter on July 2 from Nasdaq informing it that its stock had closed below the minimum $1 per share requirement for 30 consecutive days. Co-Diagnostics has 180 calendar days, or until Dec. 30, to regain compliance by having its stock close at $1 or more per share for 10 consecutive days.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.